---
title: "Cadrenal Therapeutics and Abbott to collaborate on TECH-LVAD trial"
date: "2025-03-04T13:49:14.000Z"
publishedDate: "4 mars 2025"
summary: "Cadrenal Therapeutics has announced the signing of a collaboration agreement with Abbott to support Cadrenal’s pivotal TECH-LVAD trial. Cadrenal Therapeutics is a late-stage biopharmaceutical company focused on developing specialised therapeutics for rare cardiovascular conditions."
importance: ""
sourceUrl: "https://cardiovascularnews.com/cadrenal-therapeutics-and-abbott-to-collaborate-on-tech-lvad-trial/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-03-04-cadrenal-therapeutics-and-abbott-to-collaborate-on-tech-lvad-trial"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/St_Jude_Medical_HeartMate3_main.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/cadrenal-therapeutics-and-abbott-to-collaborate-on-tech-lvad-trial/"
---

![Cadrenal Therapeutics and Abbott to collaborate on TECH-LVAD trial](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/St_Jude_Medical_HeartMate3_main.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/cadrenal-therapeutics-and-abbott-to-collaborate-on-tech-lvad-trial/*

## L’essentiel

Cadrenal Therapeutics has announced the signing of a collaboration agreement with Abbott to support Cadrenal’s pivotal TECH-LVAD trial. Cadrenal Therapeutics is a late-stage biopharmaceutical company focused on developing specialised therapeutics for rare cardiovascular conditions.

## Lien source

https://cardiovascularnews.com/cadrenal-therapeutics-and-abbott-to-collaborate-on-tech-lvad-trial/
